These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7097723)

  • 21. 1-(Aminomethyl)-6,7-dihydroxytetralin derivatives: synthesis and assessment of dopamine-like effects.
    Cannon JG; Perez Z; Long JP; Ilhan M
    J Med Chem; 1983 Jun; 26(6):813-6. PubMed ID: 6854584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Central and peripheral dopaminergic mechanisms in the cardiovascular actions of pergolide in neurogenic hypertensive dogs.
    Barrett RJ; Lokhandwala MF
    Eur J Pharmacol; 1983 Dec; 96(3-4):211-26. PubMed ID: 6676105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modification of cardiovascular actions of 2-amino-5,6-dihydroxytetralin by N,N-di-n-propyl substitution.
    Kohli JD; Goldberg LI; McDermed JD
    Eur J Pharmacol; 1982 Jul; 81(2):293-9. PubMed ID: 6126371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specific dopamine D-1 and DA1 properties of 4-(mono- and -dihydroxyphenyl)-1,2,3,4-tetrahydroisoquinoline and its tetrahydrothieno[2,3-c]pyridine analogue.
    Riggs RM; Nichols DE; Foreman MM; Truex LL; Glock D; Kohli JD
    J Med Chem; 1987 Aug; 30(8):1454-8. PubMed ID: 2956423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on cardiotonic agents. I. Synthesis of some quinazoline derivatives.
    Nomoto Y; Obase H; Takai H; Hirata T; Teranishi M; Nakamura J; Kubo K
    Chem Pharm Bull (Tokyo); 1990 Jun; 38(6):1591-5. PubMed ID: 2208370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of plasma cholinesterase prevents the dopamine DA-1 receptor mediated renal vasodilation produced by ibopamine.
    Nichols AJ; Shebuski RJ; Ruffolo RR
    Eur J Pharmacol; 1987 Sep; 141(3):515-8. PubMed ID: 3666046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and dopamine agonist and antagonist effects of (R)-(-)- and (S)-(+)-11-hydroxy-N-n-propylnoraporphine.
    Gao Y; Zong R; Campbell A; Kula NS; Baldessarini RJ; Neumeyer JL
    J Med Chem; 1988 Jul; 31(7):1392-6. PubMed ID: 3385732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine receptor agonists: new angularly annulated tricyclic compounds.
    Perrone R; Berardi F; Bettoni G; Tortorella V
    Farmaco Sci; 1988 Jan; 43(1):61-9. PubMed ID: 3396689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation of 7-oxaaporphine derivatives and evaluation of their dopaminergic activity.
    Banzatti C; Carfagna N; Commisso R; Heidempergher F; Pegrassi L; Melloni P
    J Med Chem; 1988 Jul; 31(7):1466-71. PubMed ID: 2968456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. (+/-)-3-Allyl-6-bromo-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3- benzazepin, a new high-affinity D1 dopamine receptor ligand: synthesis and structure-activity relationship.
    Neumeyer JL; Baindur N; Niznik HB; Guan HC; Seeman P
    J Med Chem; 1991 Dec; 34(12):3366-71. PubMed ID: 1684995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conformationally restricted congeners of dopamine derived from 2-aminoindan.
    Cannon JG; Perez JA; Bhatnagar RK; Long JP; Sharabi FM
    J Med Chem; 1982 Dec; 25(12):1442-6. PubMed ID: 7154005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological profiles of the putative dopamine autoreceptor agonists 3-PPP and TL-99.
    Martin GE; Haubrich DR; Williams M
    Eur J Pharmacol; 1981 Nov; 76(1):15-23. PubMed ID: 7318920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Manipulation of dopamine receptors alters hypoxic pulmonary vasoconstriction in isolated perfused rat lungs.
    Polak MJ; Kennedy LA; Drummond WH
    Life Sci; 1992; 51(17):1317-23. PubMed ID: 1357520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppression of sympathetic ganglionic neurotransmission by the selective dopamine-1 receptor agonist fenoldopam (SK&F 82526) in the anesthetized dog.
    Shebuski RJ; Fujita T; Smith JM; Kopaciewicz LJ; Blumberg AL; Hieble JP
    J Pharmacol Exp Ther; 1985 Dec; 235(3):735-40. PubMed ID: 2867207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resolution of 5,6-dihydroxy-2-(N,N-di-n-propylamino)tetralin in relation to the structural and stereochemical requirements for centrally acting dopamine agonists.
    Grol CJ; Jansen LJ; Rollema H
    J Med Chem; 1985 May; 28(5):679-83. PubMed ID: 4039369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopexamine: a novel agonist at peripheral dopamine receptors and beta 2-adrenoceptors.
    Brown RA; Dixon J; Farmer JB; Hall JC; Humphries RG; Ince F; O'Connor SE; Simpson WT; Smith GW
    Br J Pharmacol; 1985 Jul; 85(3):599-608. PubMed ID: 2862944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The search for compounds with dopaminergic action. V. Synthesis of piribedil analogs].
    Woliński J; Kujawa T
    Acta Pol Pharm; 1987; 44(2):143-6. PubMed ID: 2893511
    [No Abstract]   [Full Text] [Related]  

  • 38. Dopamine D2-receptor affinities of resolved C1-dimethylated 2-aminotetralins.
    Krotowska A; Nordvall G; Mellin C; Johansson AM; Hacksell U
    Acta Pharm Suec; 1987; 24(4):145-52. PubMed ID: 2964166
    [No Abstract]   [Full Text] [Related]  

  • 39. Synthesis, fungicidal activity, and sterol 14α-demethylase binding interaction of 2-azolyl-3,4-dihydroquinazolines on Penicillium digitatum.
    Li WJ; Li Q; Liu DL; Ding MW
    J Agric Food Chem; 2013 Feb; 61(7):1419-26. PubMed ID: 23350742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An investigation of the structural requirements for dopamine-like renal vasodilation: phenylethylamines and apomorphine.
    Goldberg LI; Sonneville PF; McNay JL
    J Pharmacol Exp Ther; 1968 Sep; 163(1):188-97. PubMed ID: 5673705
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.